Imricor Medical Systems 1H 2024 Investor Presentation

Imricor presented its 1H 2024 financial results and business update, showcasing the Vision-MR ablation catheter and Advantage-MR EP recorder/stimulator for cardiac MRI procedures. The company highlighted its position as the world's only MRI-compatible ablation catheter provider, with FDA trials underway and 15 active hospital installations across 8 countries in the growing 8.2% CAGR cardiac electrophysiology market.